Thymosin-beta 4, and Human Vitronectin peptides Grafted to Collagen Tune Adhesion or VEGF Gene Expression in Human Cell Lines

In order to improve collagen bioactivity for regenerative medicine approaches, thymosin-beta 4 (T beta 4P) and Human Vitronectin (HVP) derived peptides are grafted to collagen by thiol-ene Michael addition. T beta 4P and HVP are known to exert a pro-angiogenic and a pro-adhesive activity respectively and HVP is involved in osteogenesis promotion. The ability of these peptides to increase collagen cell adhesion and angiogenesis properties is assessed on human cell lines. In particular, HVP-grafted collagen increased human osteoblast adhesion and cell proliferation: after 24 h, both adhesion and proliferation roughly showed a 4-fold increase, if compared to pristine collagen. T beta 4P-grafted collagen promotes Vascular Endothelial Growth Factor (VEGF) gene expression in human vascular cell lines by more than 7 times. These results suggest that HVP-grafted collagen may be an interesting biomaterial for bone tissue regeneration, while T beta 4P-grafted collagen is useful for angiogenesis promotion.